Fisher & Paykel Healthcare Corporation Limited has provided a copy of its Interim Report for the six months ended 30 September 2013. The Interim Report is available online at http://www.fphcare.com/investor/annual-interim-reports.
Contact: Tony Barclay, Company Secretary on +64 9 574 0119. For more information about the company visit our website www.fphcare.com.
Interim Report 2014
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment